Diligence memo · auto-generated · as of July 2, 2026

Imricor Medical Systems Inc

Imricor Medical Systems Inc looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Imricor Medical Systems Inc operates in Healthtech, based in BURNSVILLE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Imricor Medical Systems Inc has raised $11M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $4.1M on 2011-09-01.

Most recent recorded round closed around 2019-08-29.

Valuation (modeled)modeled

Provath models Imricor Medical Systems Inc at approximately $14M (range $786K–$75M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.12× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 23 months.

Last raise 6.8 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.4× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 71% of Healthtech peers (2138 compared).

Modeled value ranks above 38% of those peers.

Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..

Peoplefiled

18 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.